Literature DB >> 19594300

Association of interleukin-15-induced peripheral immune activation with hepatic stellate cell activation in persons coinfected with hepatitis C virus and HIV.

Robert D Allison1, Antonios Katsounas, Deloris E Koziol, David E Kleiner, Harvey J Alter, Richard A Lempicki, Brad Wood, Jun Yang, Brandie Fullmer, Karoll J Cortez, Michael A Polis, Shyam Kottilil.   

Abstract

Hepatic stellate cells (HSCs) mediate hepatitis C virus (HCV)-related liver fibrosis, and increased HSC activation in human immunodeficiency virus (HIV)/HCV coinfection may be associated with accelerated fibrosis. We examined the level of HSC activation in HIV/HCV-coinfected and HCV-monoinfected subjects and its relationship to the level of activation and gene expression of peripheral immune cells in coinfected subjects. HSC activation levels positively correlated with peripheral CD4+ and CD8+ T cell immune activation and were associated with enhanced interleukin-15 (IL-15) gene expression, suggesting a pathogenic role for IL-15-driven immunomediated hepatic fibrosis. Future strategies that reduce immune activation and HSC activation may delay progression of liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594300      PMCID: PMC2806092          DOI: 10.1086/600107

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.

Authors:  A Schmitt-Gräff; S Krüger; F Bochard; G Gabbiani; H Denk
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

2.  Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.

Authors:  M Guido; M Rugge; G Leandro; I M Fiel; S N Thung
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

3.  Specific demonstration of myoepithelial cells by anti-alpha smooth muscle actin antibody.

Authors:  P Gugliotta; A Sapino; L Macrí; O Skalli; G Gabbiani; G Bussolati
Journal:  J Histochem Cytochem       Date:  1988-06       Impact factor: 2.479

4.  Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.

Authors:  Y Benhamou; M Bochet; V Di Martino; F Charlotte; F Azria; A Coutellier; M Vidaud; F Bricaire; P Opolon; C Katlama; T Poynard
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

Review 5.  Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.

Authors:  Scott L Friedman
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2004-12

6.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks
Journal:  J Infect Dis       Date:  2003-04-23       Impact factor: 5.226

7.  Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.

Authors:  D L Thomas; J W Shih; H J Alter; D Vlahov; S Cohn; D R Hoover; L Cheung; K E Nelson
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

Review 8.  Hepatitis C in the HIV-Infected Person.

Authors:  Mark S Sulkowski; David L Thomas
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

9.  CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus.

Authors:  Andrea Kovacs; Lena Al-Harthi; Shawna Christensen; Wendy Mack; Mardge Cohen; Alan Landay
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

10.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.

Authors:  O Skalli; P Ropraz; A Trzeciak; G Benzonana; D Gillessen; G Gabbiani
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  10 in total

1.  Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.

Authors:  Rebecca T Veenhuis; Jacquie Astemborski; Michael A Chattergoon; Paige Greenwood; Marissa Jarosinski; Richard D Moore; Shruti H Mehta; Andrea L Cox
Journal:  Clin Infect Dis       Date:  2016-12-07       Impact factor: 9.079

2.  Unique Cytokine/Chemokine Signatures for HIV-1 and HCV Mono-infection versus Co-infection as Determined by the Luminex® Analyses.

Authors:  Saifur Rahman; John E Connolly; Sharron L Manuel; Jihed Chehimi; Luis J Montaner; Pooja Jain
Journal:  J Clin Cell Immunol       Date:  2011-01-07

3.  Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesis.

Authors:  Angela L Rasmussen; I-Ming Wang; Margaret C Shuhart; Sean C Proll; Yudong He; Razvan Cristescu; Chris Roberts; Victoria S Carter; Christopher M Williams; Deborah L Diamond; Janine T Bryan; Roger Ulrich; Marcus J Korth; Lisa V Thomassen; Michael G Katze
Journal:  Virology       Date:  2012-05-16       Impact factor: 3.616

4.  Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy.

Authors:  Yainyrette Rivera-Rivera; Yashira García; Valerie Toro; Nydia Cappas; Pablo López; Yasuhiro Yamamura; Vanessa Rivera-Amill
Journal:  J Clin Cell Immunol       Date:  2014-12

5.  Expression profile and kinetics of cytokines and chemokines in patients with chronic hepatitis C.

Authors:  Zhen-Qi Han; Tao Huang; Yong-Zhi Deng; Guang-Ze Zhu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 6.  Hepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?

Authors:  Drosos E Karageorgopoulos; Joanna Allen; Sanjay Bhagani
Journal:  World J Hepatol       Date:  2015-07-28

7.  Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?

Authors:  Andre J Jeyarajan; Raymond T Chung
Journal:  J Infect Dis       Date:  2020-11-27       Impact factor: 5.226

8.  A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.

Authors:  Anupa Kamat; Vikas Misra; Edana Cassol; Petronela Ancuta; Zhenyu Yan; Cheng Li; Susan Morgello; Dana Gabuzda
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

9.  Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade.

Authors:  Jean Jacques N Noubiap; Peter V Aka; Aubin J Nanfack; Lucy A Agyingi; Johnson N Ngai; Phillipe N Nyambi
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

10.  HIV-1 infected peripheral blood mononuclear cells modulate the fibrogenic activity of hepatic stellate cells through secreted TGF-β and JNK signaling.

Authors:  Deepti Gupta; Manjusha Rani; Nabab Khan; Shahid Jameel
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.